Affimed N.V. (AFMDQ) vs Artelo Biosciences, Inc. (ARTL)

Affimed N.V. and Artelo Biosciences, Inc. are both Biotechnology companies. Affimed N.V. and Artelo Biosciences, Inc. are of similar size ($2.8M and $2.7M). Artelo Biosciences, Inc. has the higher net margin (0.00% vs −7,834.6%) and the higher return on invested capital (−865.9% vs −13,558.8%). Across the 14 metrics below, Artelo Biosciences, Inc. leads on 8 and Affimed N.V. on 6.

Valuation

Metric AFMDQ ARTL Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m 0.27 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.26 0.26 0.74
EV/Sales (19.16) n/m 10.73
Earnings yield 0.00% (2,586.13%) (28.84%)
Free cash flow yield 0.00% (923.67%) (23.03%)

Profitability

Metric AFMDQ ARTL Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (7,858.63%) 0.00% 0.00%
Net margin (7,834.59%) 0.00% 0.00%
Free cash flow margin (8,603.91%) 0.00% 0.00%
Return on equity (148.64%) (705.71%) (57.72%)
Return on assets (86.68%) (234.30%) (49.22%)
Return on invested capital (13,558.83%) (865.85%) 0.00%

Growth

Metric AFMDQ ARTL Biotechnology median
Revenue growth (TTM) (95.23%) — 5.64%
EPS growth (last fiscal year) (21.75%) 31.57% —
Revenue growth, 5-year CAGR (22.67%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AFMDQ ARTL Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 1.93 3.00 4.73
Net debt to EBITDA 0.58 0.05 0.96

Dividend

Metric AFMDQ ARTL Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric AFMDQ ARTL Biotechnology median
Market cap 2.76m 2.71m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack